Publications by authors named "Claire Griffaton-Tallandier"
Article Synopsis
- Medication-related osteonecrosis of the jaw (MRONJ) is a significant side effect of antiresorptive medication like denosumab, which was studied at the Institut de Cancérologie de Lorraine (ICL) to assess its incidence and extent.
- A total of 246 patients were analyzed, revealing a cumulative MRONJ incidence of 0.9% at 6 months, increasing to 15% at 24 months, suggesting a higher risk over time.
- The study found that the clinical assessment of MRONJ often underestimated its severity compared to radiological findings from cone-beam computed tomography (CBCT), indicating the need for CBCT to fully understand the extent of the condition.
